Navigation Links
Alfacell Provides ONCONASE(R) NDA Submission Update
Date:12/5/2008

utical product candidate that works in a manner similar to RNA interference (RNAi) through late-stage clinical trials. The product candidate, ONCONASE, is an RNase that overcomes the challenges of targeting RNA for therapeutic purposes while enabling the development of a new class of targeted therapies for cancer and other life-threatening diseases. For more information, visit www.alfacell.com.

Safe Harbor

This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, uncertainty whether the clinical trial results will allow the company to complete submission of a New Drug Application and if a New Drug Application submission is completed, uncertainty whether FDA will file or approve such application, uncertainties involved in transitioning from concept to product, uncertainties involving the ability of the company to finance research and development activities, potential challenges to or violations of patents, uncertainties regarding the outcome of clinical trials or differences of opinion in interpreting the results of clinical trials, the company's ability to secure necessary approvals from regulatory agencies, dependence upon third-party vendors, and other risks discussed in the company's periodic filings with the Securities and Exchange Commission. By making these forward-looking statements, the company undertakes no obligation to update these statements for revisions or changes after the date of this release.

    Media Contact:                      Investor Contact:
    David Schull or Wendy La
'/>"/>
SOURCE Alfacell Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacells ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
2. Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel
3. Alfacell Corporation Announces Preliminary Results From ONCONASE(R) Phase IIIb Clinical Trial
4. Alfacells ONCONASE(R) Shows Potential as Radiation Sensitizer for Lung Cancer Treatment
5. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
6. Alfacell Reports Financial Results for First Quarter of Fiscal 2008
7. Alfacell Corporation to Present at UBS Global Life Sciences Conference
8. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
9. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
10. Sangamo BioSciences Provides Update on Companys 2008 Progress and 2009 Objectives
11. Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... 2015 Actavis plc (NYSE: ACT ... , Chief Communications Officer, will retire from Actavis ... conjunction with Mayr,s retirement, Alex Kelly , ... Chief Communications Officer, effective immediately. Prior to joining ... President, Chief Communications Officer, Public Affairs and Investor ...
(Date:4/20/2015)... BILLERICA, Mass. , April 20, 2015 /PRNewswire/ ... tools for cell metabolism research, introduces the XFp ... a unique real-time assay on live cells that ... one-hour test measures both the mitochondrial and glycolytic ... values with metabolic activity under stressed conditions, induced ...
(Date:4/20/2015)... 2015 This report analyzes the worldwide markets for ... the following Product Segments: Sphygmomanometers (Aneroid Sphygmomanometers, & Digital Sphygmomanometers), ... report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... . Annual estimates and forecasts are provided for the period ...
Breaking Medicine Technology:Actavis Announces Retirement of Charles M. Mayr 2Actavis Announces Retirement of Charles M. Mayr 3New XFp Cell Energy Phenotype Test Determines Metabolic Potential 2New XFp Cell Energy Phenotype Test Determines Metabolic Potential 3World Blood Pressure Monitoring and Measurement Instruments Industry 2World Blood Pressure Monitoring and Measurement Instruments Industry 3World Blood Pressure Monitoring and Measurement Instruments Industry 4World Blood Pressure Monitoring and Measurement Instruments Industry 5World Blood Pressure Monitoring and Measurement Instruments Industry 6World Blood Pressure Monitoring and Measurement Instruments Industry 7World Blood Pressure Monitoring and Measurement Instruments Industry 8World Blood Pressure Monitoring and Measurement Instruments Industry 9World Blood Pressure Monitoring and Measurement Instruments Industry 10World Blood Pressure Monitoring and Measurement Instruments Industry 11World Blood Pressure Monitoring and Measurement Instruments Industry 12World Blood Pressure Monitoring and Measurement Instruments Industry 13World Blood Pressure Monitoring and Measurement Instruments Industry 14World Blood Pressure Monitoring and Measurement Instruments Industry 15World Blood Pressure Monitoring and Measurement Instruments Industry 16World Blood Pressure Monitoring and Measurement Instruments Industry 17World Blood Pressure Monitoring and Measurement Instruments Industry 18World Blood Pressure Monitoring and Measurement Instruments Industry 19World Blood Pressure Monitoring and Measurement Instruments Industry 20World Blood Pressure Monitoring and Measurement Instruments Industry 21World Blood Pressure Monitoring and Measurement Instruments Industry 22World Blood Pressure Monitoring and Measurement Instruments Industry 23World Blood Pressure Monitoring and Measurement Instruments Industry 24World Blood Pressure Monitoring and Measurement Instruments Industry 25World Blood Pressure Monitoring and Measurement Instruments Industry 26World Blood Pressure Monitoring and Measurement Instruments Industry 27World Blood Pressure Monitoring and Measurement Instruments Industry 28
... WIRE)--May 14, 2007 - Oculus Innovative,Sciences, Inc. ... the subject of a poster presentation at ... was held in,Glasgow, Scotland this past week., ... Antimicrobial,Solution in the Treatment of Infected Chronic ...
... Symptom Severity; New,Resources for Patients, Parents, WASHINGTON, May ... by the National Consumers League shows that American,asthma ... Four in,ten asthma sufferers understand asthma medication categories,somewhat ... the diagnosis, the less,knowledgeable adult patients tend to ...
Cached Medicine Technology:Oculus Innovative Sciences Microcyn Technology Presented in Poster,at European Wound Management Association Conference 2Oculus Innovative Sciences Microcyn Technology Presented in Poster,at European Wound Management Association Conference 3New Survey Finds Troubling Data on American Asthma Sufferers 2New Survey Finds Troubling Data on American Asthma Sufferers 3New Survey Finds Troubling Data on American Asthma Sufferers 4New Survey Finds Troubling Data on American Asthma Sufferers 5New Survey Finds Troubling Data on American Asthma Sufferers 6
(Date:4/21/2015)... Renewable energy, sustainable living, the greening ... Earth Day topics USM Studios ’ programming covers ... the affect of climate change on the planet, the ... touching on the environmental concerns affecting the nation and ... sustainable lifestyles, clean air options, and much more when ...
(Date:4/21/2015)... On Saturday, May 2nd, 2015, board certified ophthalmologist ... from Georgia Eye Physicians and Surgeons will ... held in Piedmont Park by the Lupus Foundation of ... largest LFA-sponsored walk in the nation, hosting more than ... awareness for lupus, an unpredictable and potentially fatal autoimmune ...
(Date:4/21/2015)... April 21, 2015 Invictus Medical ... prestigious Illinois university for a second innovative technology ... more conducive to newborn infants’ cognitive development. , ... NICU problems we have identified through extensive interviews ... said George Hutchinson, Invictus Medical’s Chief Technology Officer. ...
(Date:4/21/2015)... CA (PRWEB) April 21, 2015 “The warm ... SunGrubbies.com. “Doesn’t every mother want to look younger than her ... is the first line of defense. Signs of ... are the evidence of too much time spent in the ... only reason to cover up. The dangers of UV ...
(Date:4/20/2015)... Heritage Woods of Centralia, a Gardant ... and Dine-and-Dash Spaghetti Dinner from 4 p.m. to 6 ... located in Centralia, Illinois, houses senior living apartments, affordable ... 55 and older. , Guests are invited to tour ... options for seniors. After the tours, they can take ...
Breaking Medicine News(10 mins):Health News:USM Studios’ Programming Focuses on the Environment 2Health News:9th Annual Walk to End Lupus Now 2Health News:9th Annual Walk to End Lupus Now 3Health News:Invictus Medical Secures Rights to Second Promising New NICU Technology 2Health News:Sun’s the Word this Mother’s Day Say’s SunGrubbies.com, a Leading Retailer of Sun Protection Products 2Health News:Heritage Woods of Centralia Senior Living Community to Host Open House and Spaghetti Dinner 2
... Mich. Want to keep your boss happy? Smile at ... like you mean it. A new study led by ... fake smile throughout the day worsen their mood and withdraw ... result of cultivating positive thoughts such as a tropical ...
... Use of the blood clot-inhibiting medication tifacogin does not ... pneumonia (sCAP), according to a study conducted by researchers ... The drug had shown some potential benefit in the ... The findings were published online ahead of the ...
... -- The portion of the brain responsible for visual reading ... by researchers from the Hebrew University of Jerusalem and France. ... read words in Braille show activity in precisely the same ... read. The findings challenge the textbook notion that the brain ...
... on the treatment of liver cancer, according to a ... used molecular-sized bubbles filled with chemotherapy drugs to prevent ... and mice. Researchers evaluated the use of molecular-sized ... agent. Ceramide is a lipid molecule naturally present in ...
... (MGH) researchers to shield the ovaries of female mammals ... passed an important milestone. A collaborative study with ... online in the journal Fertility and Sterility, reports that ... called FTY720 preserved the fertility of female rhesus monkeys ...
... Radiologists who interpret a high volume of mammograms may ... suspicious lesions are not malignant, according to a new study ... Radiology . "Contrary to our expectations, we observed no ... author, Diana S.M. Buist, Ph.D., M.P.H., senior investigator at the ...
Cached Medicine News:Health News:Study: For a better workday, smile like you mean it 2Health News:Anti-clotting agent does not improve outcomes of patients with severe pneumonia 2Health News:Anti-clotting agent does not improve outcomes of patients with severe pneumonia 3Health News:Brain doesn't need vision at all in order to 'read' material 2Health News:Brain doesn't need vision at all in order to 'read' material 3Health News:Nanotechnology may lead to new treatment of liver cancer 2Health News:Protective strategy shields primate ovaries from radiation-therapy-induced damage 2Health News:Protective strategy shields primate ovaries from radiation-therapy-induced damage 3Health News:Protective strategy shields primate ovaries from radiation-therapy-induced damage 4Health News:Higher volume reduces false positives in screening mammography 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: